Real-World Use of Immunotherapy for Hepatocellular Carcinoma
{{output}}
Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related mortality worldwide and accounts for 90% of all primary liver cancers. Chronic inflammation is the hallmark across most prevalent etiologies among which HBV is the leading cause wo... ...